Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy-Reply

Affiliations

¹ Department of Pneumology, Galdakao-Usansolo Hospital, Galdakao, Bizkaia, Spain.
² Research Unit, Basurto University Hospital-Health Services Research on Chronic Patients Network (REDISSEC), Bilbao, Bizkaia, Spain.
³ Research Unit, Galdakao-Usansolo Hospital-Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, Bizkaia, Spain.

Comment

Ane Uranga et al. JAMA Intern Med. 2017.

. 2017 Feb 1;177(2):284-285.

doi: 10.1001/jamainternmed.2016.8586.

¹ Department of Pneumology, Galdakao-Usansolo Hospital, Galdakao, Bizkaia, Spain.
² Research Unit, Basurto University Hospital-Health Services Research on Chronic Patients Network (REDISSEC), Bilbao, Bizkaia, Spain.
³ Research Unit, Galdakao-Usansolo Hospital-Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, Bizkaia, Spain.

No abstract available

Comment on

Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
Uranga A, España PP, Bilbao A, Quintana JM, Arriaga I, Intxausti M, Lobo JL, Tomás L, Camino J, Nuñez J, Capelastegui A. Uranga A, et al. JAMA Intern Med. 2016 Sep 1;176(9):1257-65. doi: 10.1001/jamainternmed.2016.3633. JAMA Intern Med. 2016. PMID: 27455166 Clinical Trial.
Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy.
Albrich WC, Huttner BD, Huttner A. Albrich WC, et al. JAMA Intern Med. 2017 Feb 1;177(2):283-284. doi: 10.1001/jamainternmed.2016.8574. JAMA Intern Med. 2017. PMID: 28166342 No abstract available.
Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy.
Mori T, Yaegashi M, Hasegawa S. Mori T, et al. JAMA Intern Med. 2017 Feb 1;177(2):284. doi: 10.1001/jamainternmed.2016.8577. JAMA Intern Med. 2017. PMID: 28166343 No abstract available.